Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs

Virology Journal

Volumn 7, Issue , 2010, Pages

  Khaliq, Saba ^a   Jahan, Shah ^a   Ijaz, Bushra ^a   Ahmad, Waqar ^a   Asad, Sultan ^a   Pervaiz, Asim ^a   Samreen, Baila ^a   Khan, Mahwish ^a   Hassan, Sajida ^a  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS VECTOR; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT; CORE PROTEIN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS RNA;

ARTICLE; CELL GROWTH; DISEASE COURSE; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; PROTEIN EXPRESSION; RNA DEGRADATION; RNA INTERFERENCE; VIRUS GENE; VIRUS INFECTIVITY; VIRUS REPLICATION; CELL LINE; DNA SEQUENCE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL; MOLECULAR GENETICS; SYNTHESIS; VIROLOGY;

HEPATITIS C VIRUS;

ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; CELL LINE; GENE EXPRESSION; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; RNA, SMALL INTERFERING; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL CORE PROTEINS;

EID: 78149349172     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-318     Document Type: Article

References (56)

1. Hepatitis C virus biology. C Giannini C Brechot, Cell Death Differ 2003 10 Suppl 1 27 S38 10.1038/sj.cdd.4401121 12655344
2. Detection of antibodies to hepatitis C virus in dried blood spot samples from mothers and their offspring in Lahore, Pakistan. SP Parker HI Khan WD Cubitt, J Clin Microbiol 1999 37 2061 2063 10325381
3. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. M Idrees S Riazuddin, BMC Infect Dis 2008 8 69 10.1186/1471-2334-8-69 18498666
4. HCV genotype distribution and possible transmission risks in Lahore, Pakistan. W Ahmad B Ijaz FT Javed S Jahan I Shahid FM Khan,, et al. World J Gastroenterol 2010 16 4321 4328 10.3748/wjg.v16.i34.4321 20818816
5. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. M Idrees S Rafique I Rehman H Akbar MZ Yousaf S Butt,, et al. World J Gastroenterol 2009 15 5080 5085 10.3748/wjg.15.5080 19860002
6. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. JJ Feld JH Hoofnagle, Nature 2005 436 967 972 10.1038/nature04082 16107837
7. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Goncales Jr,, et al. N Engl J Med 2002 347 975 982 10.1056/NEJMoa020047 12324553
8. Current therapy for hepatitis C: pegylated interferon and ribavirin. JG McHutchison MW Fried, Clin Liver Dis 2003 7 149 161 10.1016/S1089-3261(02)00077- 6 12691464
9. A system for stable expression of short interfering RNAs in mammalian cells. TR Brummelkamp R Bernards R Agami, Science 2002 296 550 553 10.1126/science.1068999 11910072
10. RNA interference - 2001. PA Sharp, Genes Dev 2001 15 485 490 10.1101/gad.880001 11238371
11. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. SM Elbashir J Harborth W Lendeckel A Yalcin K Weber T Tuschl, Nature 2001 411 494 498 10.1038/35078107 11373684
12. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. T Kanda R Steele R Ray RB Ray, J Virol 2007 81 669 676 10.1128/JVI.01496-06 17079316
13. Interference of hepatitis C virus RNA replication by short interfering RNAs. SB Kapadia A Brideau-Andersen FV Chisari, Proc Natl Acad Sci USA 2003 100 2014 2018 10.1073/pnas.252783999 12566571
14. RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. M Liu H Ding P Zhao ZL Qin J Gao MM Cao,, et al. Biosci Biotechnol Biochem 2006 70 2049 2055 10.1271/bbb.60001 16960393
15. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. R Prabhu P Vittal Q Yin E Flemington R Garry WH Robichaux,, et al. J Med Virol 2005 76 511 519 10.1002/jmv.20391 15977238
16. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. G Randall A Grakoui CM Rice, Proc Natl Acad Sci USA 2003 100 235 240 10.1073/pnas.0235524100 12518066
17. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. MY Seo S Abrignani M Houghton JH Han, J Virol 2003 77 810 812 10.1128/JVI.77.1.810-812.2003 12477890
18. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. JA Wilson S Jayasena A Khvorova S Sabatinos IG Rodrigue-Gervais S Arya,, et al. Proc Natl Acad Sci USA 2003 100 2783 2788 10.1073/pnas.252758799 12594341
19. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. T Yokota N Sakamoto N Enomoto Y Tanabe M Miyagishi S Maekawa,, et al. EMBO Rep 2003 4 602 608 10.1038/sj.embor.embor840 12740604
20. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 362 10.1126/science.2523562 2523562
21. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. M Hijikata N Kato Y Ootsuyama M Nakagawa K Shimotohno, Proc Natl Acad Sci USA 1991 88 5547 5551 10.1073/pnas.88.13.5547 1648221
22. Interaction between hepatitis C virus core protein and E1 envelope protein. SY Lo MJ Selby JH Ou, J Virol 1996 70 5177 5182 8764026
23. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J McLauchlan, J Viral Hepat 2000 7 2 14 10.1046/j.1365-2893.2000.00201.x 10718937
24. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. S Boulant C Vanbelle C Ebel F Penin JP Lavergne, J Virol 2005 79 11353 11365 10.1128/JVI.79.17.11353-11365.2005 16103187
25. Structural determinants that target the hepatitis C virus core protein to lipid droplets. S Boulant R Montserret RG Hope M Ratinier P Targett-Adams JP Lavergne,, et al. J Biol Chem 2006 281 22236 22247 10.1074/jbc.M601031200 16704979
26. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. T Fukutomi Y Zhou S Kawai H Eguchi JR Wands J Li, Hepatology 2005 41 1096 1105 10.1002/hep.20668 15841445
27. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. RG Hope DJ Murphy J McLauchlan, J Biol Chem 2002 277 4261 4270 10.1074/jbc. M108798200 11706032
28. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. DY Jin HL Wang Y Zhou AC Chun KV Kibler YD Hou,, et al. EMBO J 2000 19 729 740 10.1093/emboj/19.4.729 10675342
29. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. H Lerat M Honda MR Beard K Loesch J Sun Y Yang,, et al. Gastroenterology 2002 122 352 365 10.1053/gast.2002.31001 11832450
30. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. K Moriya H Fujie Y Shintani H Yotsuyanagi T Tsutsumi K Ishibashi,, et al. Nat Med 1998 4 1065 1067 10.1038/2053 9734402
31. Structural biology of hepatitis C virus. F Penin J Dubuisson FA Rey D Moradpour JM Pawlotsky, Hepatology 2004 39 5 19 10.1002/hep.20032 14752815
32. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. A Ruggieri T Harada Y Matsuura T Miyamura, Virology 1997 229 68 76 10.1006/viro.1996.8420 9123879 (Pubitemid 27243489)
33. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. C Hezode F Roudot-Thoraval ES Zafrani D Dhumeaux JM Pawlotsky, J Viral Hepat 2004 11 455 458 10.1111/j.1365-2893.2004.00528.x 15357652
34. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. C Hourioux R Patient A Morin E Blanchard A Moreau S Trassard,, et al. Gut 2007 56 1302 1308 10.1136/gut.2006.108647 17213339
35. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. R Jhaveri J McHutchison K Patel G Qiang AM Diehl, J Infect Dis 2008 197 283 291 10.1086/524846 18177246
36. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. S Mihm A Fayyazi H Hartmann G Ramadori, Hepatology 1997 25 735 739 10.1002/hep.510250340 9049227
37. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. L Rubbia-Brandt R Quadri K Abid E Giostra PJ Male G Mentha,, et al. J Hepatol 2000 33 106 115 10.1016/S0168-8278(00)80166-X 10905593
38. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C. Y Tachi Y Katano T Honda K Hayashi M Ishigami A Itoh,, et al. Liver Int 2009 30 554 559 10.1111/j.1478-3231.2009.02164.x 19951380
39. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. M Vidali SF Stewart E Albano, Trends Mol Med 2008 14 63 71 10.1016/j.molmed.2007.12.005 18222109
40. Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. M Buck, PLoS One 2008 3 2660 10.1371/journal.pone.0002660 18628977
41. Consensus siRNA for inhibition of HCV genotype-4 replication. AR Zekri AA Bahnassy HM El-Din HM Salama, Virol J 2009 6 13 10.1186/1743-422X-6-13 19173711
42. HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. MK el-Awady AA Tabll YS el-Abd MM Bahgat HA Shoeb SS Youssef,, et al. World J Gastroenterol 2006 12 4836 4842 16937465
43. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. S Molina V Castet L Pichard-Garcia C Wychowski E Meurs JM Pascussi,, et al. J Virol 2008 82 569 574 10.1128/JVI.01443-07 17942559
44. Hepatitis C virus genotypes and quasispecies. GL Davis, Am J Med 1999 107 21S 26S 10.1016/S0002-9343(99)00376-9 10653451
45. Genetic diversity and evolution of hepatitis C virus - 15 years on. P Simmonds, J Gen Virol 2004 85 3173 3188 10.1099/vir.0.80401-0 15483230
46. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Korner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 110 113 10.1126/science.285.5424.110 10390360
47. Complete replication of hepatitis C virus in cell culture. BD Lindenbach MJ Evans AJ Syder B Wolk TL Tellinghuisen CC Liu,, et al. Science 2005 309 623 626 10.1126/science.1114016 15947137
48. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao,, et al. Nat Med 2005 11 791 796 10.1038/nm1268 15951748
49. Robust hepatitis C virus infection in vitro. J Zhong P Gastaminza G Cheng S Kapadia T Kato DR Burton,, et al. Proc Natl Acad Sci USA 2005 102 9294 9299 10.1073/pnas.0503596102 15939869
50. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. M Kim D Shin SI Kim M Park, Virus Res 2006 122 1 10 10.1016/j.virusres.2006.05. 003 16979254
51. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. A Sabile G Perlemuter F Bono K Kohara F Demaugre M Kohara,, et al. Hepatology 1999 30 1064 1076 10.1002/hep.510300429 10498661
52. Proapoptotic and pronecrosis effect of different truncated hepatitis C virus core proteins. XB Yan Z Chen DH Luo XY Xu W Wu LF Zhou, J Zhejiang Univ Sci B 2005 6 295 300 10.1631/jzus.2005.B0295 15754428
53. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. CA Lazaro M Chang W Tang J Campbell DG Sullivan DR Gretch,, et al. Am J Pathol 2007 170 478 489 10.2353/ajpath.2007.060789 17255316
54. HCV envelope protein function is dependent on the peptides preceding the glycoproteins. T Bian Y Zhou S Bi W Tan Y Wang, Biochem Biophys Res Commun 2009 378 118 122 10.1016/j.bbrc.2008.11.024 19013428
55. Suppression of hepatitis C virus core protein by short hairpin RNA expression vectors in the core protein expression Huh-7 cells. H Suzuki H Kaneko N Tamai K Shimotohno N Miyano-Kurosaki H Takaku, Nucleosides Nucleotides Nucleic Acids 2007 26 815 820 10.1080/15257770701503787 18066906
56. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. H Suzuki N Tamai Y Habu MO Chang H Takaku, FEBS Lett 2008 582 3085 3089 10.1016/j.febslet.2008.07.056 18692048